Practice Areas - Corporate and M&A Law Firms and Lawyers
| Deal Date: | 03-06-2020 | Practice Area: | Corporate and M&A |
| Deal Title: | Aduro Biotech, Inc. Merger with Chinook Therapeutics, Inc. | Industry: | Pharmaceuticals & Biotechnology |
| Description: |
Aduro Biotech, Inc. (Aduro) (NASDAQ: ADRO) and Chinook Therapeutics, Inc. (Chinook), a privately held clinical-stage biotechnology company focused on the discovery, development, and commercialization of precision medicines for kidney diseases, announced that the companies entered into a definitive merger agreement pursuant to which Aduro would acquire all of the outstanding capital stock of Chinook in exchange for shares of Aduro common stock representing approximately 50% of Aduro's outstanding common stock immediately following completion of the transaction.
Latham and Watkins LLP represents Aduro in the transaction.
|
||
| Financial Center: | Silicon Valley | Value: | 0.00-0.00 |
| Advised Party: | Merger Party | Law Firm | Latham & Watkins |
| Merger Party Jurisdiction | United States | Merger Party Jurisdiction | United States |
| Classification: |
Mergers |
Lawyer | Luke Bergstrom |
